Skip to main content

Advertisement

Table 2 Differences between baseline and 12 ± 3 months

From: Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes

Variable Baseline 12 ± 3 months Interval difference P*
kurtosis 1.26 (0.41, 2.26) 0.94 (0.01, 1.53) −0.32 0.25
skewness 1.34 (1.07, 1.53) 1.15 (0.87, 1.41) −0.19 0.25
MLD − 777.92 (− 801.37, − 745.61) − 764.76 (− 786.15, − 733.01) −13.16 0.40
HAA% 14.42 (10.74, 17.79) 15.19 (12.81, 20.45) 0.77 0.40
FA% 24.68 (19.06, 32.00) 26.69 (22.14, 33.97) 2.01 0.68
FVC% 86 (75, 96) 85 (76.5, 105.25) −1 0.88
DLCO% 67 (56, 72.50) 53 (40.75, 68.75) −14 0.02
GAP (points) 3 (2.25, 4) 3 (3, 4) 0 0.21
  1. Data are expressed as median (interquartile range)
  2. aMLD Mean Lung Density, bHAA High attenuation areas, cFA Fibrotic Areas, dFVC Forced Vital Capacity, eDLCO Diffusing Capacity for carbon monoxide, fGAP Gender-Age-Physiology index, * Reported pwere adjusted with Holm’s correction